ResMed (RMD) beats earnings and revenue estimates and reaffirms full-year outlook
FROM THE WIRE · FINANCE.YAHOO.COM
ResMed (RMD) just posted quarterly results that topped analyst expectations on both earnings and revenue, while reaffirming its full year outlook and highlighting firm demand for sleep devices, masks, and digital health tools. ResMed's share price has climbed 13.5% over the past…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishAn earnings and revenue beat with a reaffirmed outlook is relevant for ResMed's share price after its recent run.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01ResMed posted quarterly results that topped analyst expectations on earnings and revenue.
- 02The company reaffirmed its full-year outlook and cited firm demand for sleep devices, masks and digital health tools.
- 03Shares rose 13.5% over the past month and 19.8% over the last 90 days.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
ResMed Inc.229.94 USDMarket closedtoday -9.05%Positive ResMed Inc.24.70 USDMarket closedtoday +9.24%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets